Gender IdentityNCT03175445
Sexual Dimorphism Analysis in Egyptian Population by Locating the Mandibular Canal Using CBCT
An observational study of Gender Identity, run by Cairo University at 1 site in Egypt.
Trial summary
Sexual dimorphism analysis in Egyptian population by locating the mandibular canal using cone-beam computed tomography: an observational cross sectional study Read more about this study
- Who is it for?
- Ages 18 to 88 yearsHealthy volunteers can take part
- Conditions the study is for
- Gender Identity
- What is being tested?
- CBCT scan by planmeca promax
- How many people
- 136 participants
- Where
- 1 siteEgypt
- Study dates
- 30 Jan 2017to 1 Jan 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 88 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Adult Egyptian population
Who may be able to join
- 18 years and above.
- Absence of large pathological lesions in mandible.
- Dentulous patients
Who cannot join
- Patients younger than 18 years old
- Presence of large pathological lesions in mandible
- Completely edentulous patients.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Sexual Dimorphism Analysis in Egyptian Population by Locating the Mandibular Canal Using Cone-beam Computed Tomography: an Observational Cross Sectional Study
Sexual dimorphism analysis in Egyptian population by locating the mandibular canal using cone-beam computed tomography: an observational cross sectional study
Read the detailed description
Many studies from different countries such as United States, China, Japan, and Europe were done to observe the distinct morphologic and morphometric manifestations of sexual dimorphism. Accordingly, it is mandatory to target a specific population with their unique skeletal features.
- Conditions
- Gender Identity
- Being tested
- CBCT scan by planmeca promax
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CBCT scan by planmeca promaxOther
software measurement tool of CBCT
| Study group | Role | What they receive |
|---|---|---|
| mandible CBCT scans in males | 74 males CBCT scan by planmeca promax 3D Mid machine using 90 kVp, 10 mA, 14 seconds and 200×60 mm FOV with a 0.2 mm voxel size. Receives: Other: CBCT scan by planmeca promax | |
| mandible CBCT scans in female | 74 females CBCT scan by planmeca promax 3D Mid machine using 90 kVp, 10 mA, 14 seconds and 200×60 mm FOV with a 0.2 mm voxel size Receives: Other: CBCT scan by planmeca promax |
What is being measured
The primary outcome is the main question the study is designed to answer.
Anterior ramus width , posterior ramus width
distance from mandibular foramen to most anterior and posterior points of ramus respectively
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jun 2017
- Study start30 Jan 2017
- Primary completion30 Dec 2017 (estimated)
- Study completion1 Jan 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gender IdentityStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 136 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Arwa Mousa, Cairo University
- Investigators
- Arwa Mousa, Principal investigator, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03175445
- Sponsor's protocol ID
- CEBD-CU-2017-05-09
- Status last verified
- Jun 2017
- First submitted
- 30 May 2017
- Last updated
- 5 Jun 2017
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 5 Jun 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sexual Dimorphism Analysis in Egyptian Population by Locating the Mandibular Canal Using Cone-beam Computed Tomography: an Observational Cross Sectional Study
- ClinicalTrials.gov ID
- NCT03175445
- Acronym / sponsor ID
- CEBD-CU-2017-05-09
- Conditions
- Gender Identity
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 136 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 30 Jan 2017 (actual)
- Primary completion
- 30 Dec 2017 (estimated)
- Study completion
- 1 Jan 2019 (estimated)
- First posted
- 5 Jun 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Sexual dimorphism analysis in Egyptian population by locating the mandibular canal using cone-beam computed tomography: an observational cross sectional study
Detailed description
Many studies from different countries such as United States, China, Japan, and Europe were done to observe the distinct morphologic and morphometric manifestations of sexual dimorphism. Accordingly, it is mandatory to target a specific population with their unique skeletal features.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| mandible CBCT scans in males | – | Other: CBCT scan by planmeca promax74 males CBCT scan by planmeca promax 3D Mid machine using 90 kVp, 10 mA, 14 seconds and 200×60 mm FOV with a 0.2 mm voxel size. |
| mandible CBCT scans in female | – | Other: CBCT scan by planmeca promax74 females CBCT scan by planmeca promax 3D Mid machine using 90 kVp, 10 mA, 14 seconds and 200×60 mm FOV with a 0.2 mm voxel size |
Who may qualify
- Ages
- 18 to 88 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Adult Egyptian population
Key inclusion criteria (3 listed)
- 18 years and above.
- Absence of large pathological lesions in mandible.
- Dentulous patients
Key exclusion criteria (3 listed)
- Patients younger than 18 years old
- Presence of large pathological lesions in mandible
- Completely edentulous patients.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CBCT scan by planmeca promaxsoftware measurement tool of CBCT | Other | mandible CBCT scans in female, mandible CBCT scans in males |
Primary outcome
Anterior ramus width , posterior ramus width
Time frame: 2 years
distance from mandibular foramen to most anterior and posterior points of ramus respectively
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jun 2017.
- Individual participant dataSharing planned: Undecided
Related trials for Gender Identity
Recruiting
Demographic Data Collection in Healthcare
Implementation Strategies
Enrolling by invitation
Efficacy of a Chronic Pain Treatment Prior to Gender-affirming Surgery
Pain Catastrophizing, Pain, Chronic
RecruitingObservational study
Comparative Study of Gender Identity Disorder Versus Control
Gender Dysphoria, Adult
RecruitingObservational study
Puberty, Testosterone, and Brain Development
Gender Identity, Gender Dysphoria in Adolescents and Adults
Active, not recruitingObservational study
Effect of Hormones on Frequency of Headache and Brain Structure and Function in Puberty
Headache, Gender Identity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Arwa Mousa principal investigator
Cairo University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Gender Identity, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Anterior ramus width , posterior ramus width (time frame: 2 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2017.